Skip to main content
Clinical Trials/NL-OMON55138
NL-OMON55138
Completed
Not Applicable

IXSI: Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA during the radioembolisation pretreatment procedure - IXSI

niversitair Medisch Centrum Utrecht0 sites15 target enrollmentStarted: TBDLast updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
15

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1\. Participants must have given written informed consent and comply
  • with the requirements of the study protocol.
  • 2\. Must be aged 18 years or over.
  • 3\. Must be selected to undergo a 99mTc\-MAA procedure as part of their
  • radioembolisation treatment.
  • 4\. Sufficiently fit to undergo an additional examination time of
  • 30\-90 minutes.
  • 5\. Have a CT acquired less than 6 weeks before the pre\-treatment
  • radioembolisation procedure.

Exclusion Criteria

  • 1\. Patients expected to require more than two injection positions for
  • radioembolisation treatment.
  • 2\. Pregnancy or nursing.
  • 3\. Patients suffering from psychic disorders that make a comprehensive
  • judgement impossible, such as psychosis, hallucinations and/or depression.
  • 4\. Patients who are declared incompetent.
  • 5\. Previous enrollment in the present study
  • 6\. Claustrophobia
  • 7\. The last dose of prior chemotherapy has been received less than 4 weeks
  • prior to the planned 99mTc\-MAA pretreatment procedure.

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials